Clinical trials
Phase 4 Pancreatic Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 1 |
| Peking University First Hospital | 1 |
| Pfizer | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
| Wei Zhou | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 6 |
| Adenoma | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Neoplasms | 1 |
| Neuroendocrine Tumors | 1 |
| Stomach Neoplasms | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.